Experts fear new variants of COVID-19 from South Africa and Brazil may be resistant to existing vaccines and treatment.
Pfizer says trials suggest vaccine 91% effective against variant from South Africa
Experts fear new variants of COVID-19 from South Africa and Brazil may be resistant to existing vaccines and treatment.